Document is current
Any future updates will be listed below
-
Authors
Akuta, Norio
Kawamura, Yusuke
Arase, Yasuji
Saitoh, Satoshi
Fujiyama, Shunichiro
Sezaki, Hitomi
Hosaka, Tetsuya
Kobayashi, Masahiro
Kobayashi, Mariko
Suzuki, Yoshiyuki
Suzuki, Fumitaka
Ikeda, Kenji
Kumada, Hiromitsu
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (17fk0210304h0003)
- License Information
-
More Information
Article History
Received: 28 May 2018
Accepted: 25 October 2018
First Online: 6 November 2018
Ethics approval and consent to participate
: The study was conducted in compliance with the International Conference on Harmonization guidelines for Good Clinical Practice (E6) and the 2013 Declaration of Helsinki. The protocol was approved by the institutional review board at Toranomon Hospital (number; 953). Written informed consent was provided by all patients prior to liver biopsy.
: Not Applicable.
: (1) Hiromitsu Kumada has received honoraria from MSD K.K., Bristol-Myers Squibb, Gilead Sciences, AbbVie Inc., and Dainippon Sumitomo Pharma. (2) Norio Akuta has received an honorarium from Bristol-Myers Squibb and AbbVie Inc. (3) Yoshiyuki Suzuki has received an honorarium from Bristol-Myers Squibb and AbbVie Inc. All other authors declare no conflict of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
